BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4288552)

  • 1. The metabolism of 4-nitroquinoline-1-oxide, a carcinogen. 3. An enzyme catalyzing the conversion of 4-nitroquinoline-1-oxide to 4-hydroxyaminoquinoline-1-oxide in rat liver and hepatomas.
    Sugimura T; Okabe K; Nagao M
    Cancer Res; 1966 Aug; 26(8):1717-21. PubMed ID: 4288552
    [No Abstract]   [Full Text] [Related]  

  • 2. Different deviation patterns of carbohydrate-metabolizing enzymes in primary rat hepatomas induced by different chemical carcinogens.
    Sato K; Takaya S; Imai F; Hatayama I; Ito N
    Cancer Res; 1978 Sep; 38(9):3086-93. PubMed ID: 209895
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of activating enzymes for 4-nitroquinoline 1-oxide activation with a microbial assay system.
    Fukuda S; Yamamoto N
    Cancer Res; 1972 Feb; 32(2):435-9. PubMed ID: 4550746
    [No Abstract]   [Full Text] [Related]  

  • 4. The enzymology of methionine metabolism in rat hepatomas.
    Grossman MR; Finkelstein JD; Kyle WE; Morris HP
    Cancer Res; 1974 Apr; 34(4):794-800. PubMed ID: 4360840
    [No Abstract]   [Full Text] [Related]  

  • 5. Free radical induced in rat liver by a chemical carcinogen, N-methyl-N'-nitro-N-nitrosoguanidine.
    Nagata C; Ioki Y; Kodama M; Tagashira Y; Nakadate M
    Ann N Y Acad Sci; 1973 Dec; 222():1031-47. PubMed ID: 4361846
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzymatic activation of the carcinogen 4-hydroxyaminoquinoline-1-oxide and its interaction with cellular macromolecules.
    Tada M; Tada M
    Biochem Biophys Res Commun; 1972 Jan; 46(2):1025-32. PubMed ID: 4333412
    [No Abstract]   [Full Text] [Related]  

  • 7. Defective dietary control of fatty acid metabolism in four transplantable rat hepatomas: numbers 5123C, 7793, 7795, and 7800.
    Sabine JR; Abraham S; Morris HP
    Cancer Res; 1968 Jan; 28(1):46-51. PubMed ID: 4294912
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo interaction of 4-nitroquinoline-1-oxide and its derivatives with DNA.
    Matsushima T; Kobuna I; Sugimura T
    Nature; 1967 Nov; 216(5114):508. PubMed ID: 4293602
    [No Abstract]   [Full Text] [Related]  

  • 9. [Distribution of a carcinogen-binding protein in primary liver tumors induced by 3-methyl-4-dimethylaminoazobenzene in rats].
    Bannikov GA; Gel'shteĭn VI; Chipysheva TA
    Biull Eksp Biol Med; 1973 Mar; 75(3):90-2. PubMed ID: 4374978
    [No Abstract]   [Full Text] [Related]  

  • 10. On protein binding of fluorenyl carcinogens by minimal deviation hepatomas.
    Sorof S; Young EM; Coffey CB; Morris HP
    Cancer Res; 1966 Jan; 26(1):81-8. PubMed ID: 4285305
    [No Abstract]   [Full Text] [Related]  

  • 11. Systematic oscillations in metabolic activity in rat liver and in hepatomas. I. Morris hepatoma No. 7793.
    Potter VR; Gebert RA; Pitot HC; Peraino C; Lamar C; Lesher S; Morris HP
    Cancer Res; 1966 Jul; 26(7):1547-60. PubMed ID: 4287850
    [No Abstract]   [Full Text] [Related]  

  • 12. Early events during liver carcinogenesis involving two carcinogen:protein complexes.
    Blackburn GR; Andrews JP; Custer RP; Sorof S
    Cancer Res; 1981 Oct; 41(10):4039-49. PubMed ID: 6269733
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of lipid composition on some physical and functional properties of cellular membranes in rat liver and hepatomas.
    Feo F; Canuto RA; Garcea R; Gabriel L
    Panminerva Med; 1976; 18(11-12):454-71. PubMed ID: 186744
    [No Abstract]   [Full Text] [Related]  

  • 14. [Electron microscopic localization of nucleoside phosphatase activity in plasma membrane of rat liver and hepatomas].
    Usui T
    Kumamoto Igakkai Zasshi; 1967 Jan; 41(1):71-80. PubMed ID: 4292175
    [No Abstract]   [Full Text] [Related]  

  • 15. The content of the principal protein target of a hepatic carcinogen in liver tumors.
    Mott DM; Sani BP; Sorof S
    Cancer Res; 1973 Nov; 33(11):2721-5. PubMed ID: 4355980
    [No Abstract]   [Full Text] [Related]  

  • 16. On the significance of glucolysis for cancer growth, with special reference to Morris rat hepatomas.
    Burk D; Woods M; Hunter J
    J Natl Cancer Inst; 1967 Jun; 38(6):839-63. PubMed ID: 4381692
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism of 4-nitroquinoline 1-oxide. IV. Quantitative determination of in vivo conversion of 4-nitroquinoline 1-oxide in subcutaneous tissue of rat.
    Matsushima T; Kobuna I; Fukuoka F; Sugimura T
    Gan; 1968 Jun; 59(3):247-50. PubMed ID: 5726266
    [No Abstract]   [Full Text] [Related]  

  • 18. The metabolism of 4-nitroquinoline 1-oxide. I. Conversion of 4-nitroquinoline 1-oxide to 4-aminoquinoline 1-oxide by rat liver enzymes.
    Sugimura T; Okabe K; Endo H
    Gan; 1965 Oct; 56(5):489-501. PubMed ID: 5850748
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of 4-nitroquinoline 1-oxide. II. In vivo conversion of subcutaneously injected 4-nitroquinoline 1-oxide to 4-aminoquinoline 1-oxide and 4-hydroxyquinoline 1-oxide in rats.
    Hoshino H; Fukuoka F; Okabe K; Sugimura T
    Gan; 1966 Feb; 57(1):71-4. PubMed ID: 5956663
    [No Abstract]   [Full Text] [Related]  

  • 20. Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in behavior of L-ornithine:2-oxoacid aminotransferase (ornithine transaminase, EC 2.6.1.13).
    Tomino I; Katunuma N; Morris HP; Weber G
    Cancer Res; 1974 Mar; 34(3):627-36. PubMed ID: 4359884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.